The Board of Directors of Biora resolved to convene an Extraordinary
Shareholders' Meeting on Wednesday August 6, 2003 at 1:00 pm at Medeon
Science Park, Malmö, due to the accomplished change of ownership. The
notice is attached hereto.

Biora develops manufactures and sells biotechnology-based products to
dentists. Its principal product, Emdogain®Gel, which is approved for
sale in Europe, North America and Japan among others, naturally
regenerates tooth-supporting structure that the tooth has lost due to
periodontitis. Biora's shares are listed on the "O-list" of the
Stockholm Stock Exchange in Sweden.

This press release may contain certain forward- looking statements that
relate to future events or future business and financial performance.
Such statements can only be predictions and the actual events or results
may differ from those discussed. The Company cautions that these
statements are subject to...